- Home
- CLOV vs VCEL Comparison
CLOV vs VCEL Comparison
Compare CLOV & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLOV
- VCEL
- Stock Information
- Founded
- CLOV 2014
- VCEL 1989
- Country
- CLOV United States
- VCEL United States
- Employees
- CLOV N/A
- VCEL N/A
- Industry
- CLOV Medical Specialities
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLOV Health Care
- VCEL Health Care
- Exchange
- CLOV Nasdaq
- VCEL Nasdaq
- Market Cap
- CLOV 1.8B
- VCEL 2.1B
- IPO Year
- CLOV N/A
- VCEL 1997
- Fundamental
- Price
- CLOV $3.00
- VCEL $39.98
- Analyst Decision
- CLOV Strong Buy
- VCEL Strong Buy
- Analyst Count
- CLOV 3
- VCEL 8
- Target Price
- CLOV $4.83
- VCEL $62.00
- AVG Volume (30 Days)
- CLOV 12.4M
- VCEL 463.0K
- Earning Date
- CLOV 08-05-2025
- VCEL 07-31-2025
- Dividend Yield
- CLOV N/A
- VCEL N/A
- EPS Growth
- CLOV N/A
- VCEL 521.85
- EPS
- CLOV N/A
- VCEL 0.05
- Revenue
- CLOV $1,486,540,000.00
- VCEL $238,541,000.00
- Revenue This Year
- CLOV $38.62
- VCEL $23.03
- Revenue Next Year
- CLOV $22.21
- VCEL $24.52
- P/E Ratio
- CLOV N/A
- VCEL $771.35
- Revenue Growth
- CLOV 15.62
- VCEL 14.80
- 52 Week Low
- CLOV $1.50
- VCEL $37.39
- 52 Week High
- CLOV $4.87
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- CLOV 48.55
- VCEL 42.08
- Support Level
- CLOV $2.54
- VCEL $39.39
- Resistance Level
- CLOV $3.28
- VCEL $42.61
- Average True Range (ATR)
- CLOV 0.17
- VCEL 1.61
- MACD
- CLOV 0.05
- VCEL -0.20
- Stochastic Oscillator
- CLOV 51.49
- VCEL 11.60
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.